191 related articles for article (PubMed ID: 15639473)
21. Gastric preconditioning induced by short ischemia: the role of prostaglandins, nitric oxide and adenosine.
Konturek SJ; Brzozowski T; Pajdo R; Konturek PC; Kwiecień S; Sliwowski Z; Pawlik M; Ptak A; Drozdowicz D; Hahn EG
Med Sci Monit; 2001; 7(4):610-21. PubMed ID: 11433185
[TBL] [Abstract][Full Text] [Related]
22. Effects of acute and chronic atorvastatin on cardioprotection of ischemic postconditioning in isolated rat hearts.
Fan Y; Yang S; Cao Y; Huang Y
Cardiovasc Ther; 2013 Aug; 31(4):187-92. PubMed ID: 22954178
[TBL] [Abstract][Full Text] [Related]
23. Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2.
Ye Y; Nishi SP; Manickavasagam S; Lin Y; Huang MH; Perez-Polo JR; Uretsky BF; Birnbaum Y
Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):43-53. PubMed ID: 17643887
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA
Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896
[TBL] [Abstract][Full Text] [Related]
25. Cardioprotection during the final stage of the late phase of ischemic preconditioning is mediated by neuronal NO synthase in concert with cyclooxygenase-2.
Wang Y; Kodani E; Wang J; Zhang SX; Takano H; Tang XL; Bolli R
Circ Res; 2004 Jul; 95(1):84-91. PubMed ID: 15166094
[TBL] [Abstract][Full Text] [Related]
26. Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism.
Li Q; Guo Y; Xuan YT; Lowenstein CJ; Stevenson SC; Prabhu SD; Wu WJ; Zhu Y; Bolli R
Circ Res; 2003 Apr; 92(7):741-8. PubMed ID: 12702642
[TBL] [Abstract][Full Text] [Related]
27. Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress.
Zhou MS; Jaimes EA; Raij L
Hypertension; 2004 Aug; 44(2):186-90. PubMed ID: 15238570
[TBL] [Abstract][Full Text] [Related]
28. Pretreatment with high-dose statin, but not low-dose statin, ezetimibe, or the combination of low-dose statin and ezetimibe, limits infarct size in the rat.
Birnbaum Y; Lin Y; Ye Y; Merla R; Perez-Polo JR; Uretsky BF
J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):72-9. PubMed ID: 18287593
[TBL] [Abstract][Full Text] [Related]
29. HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage.
Jung KH; Chu K; Jeong SW; Han SY; Lee ST; Kim JY; Kim M; Roh JK
Stroke; 2004 Jul; 35(7):1744-9. PubMed ID: 15166393
[TBL] [Abstract][Full Text] [Related]
30. Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart.
Faghihi M; Mirershadi F; Dehpour AR; Bazargan M
Eur J Pharmacol; 2008 Nov; 597(1-3):57-63. PubMed ID: 18789320
[TBL] [Abstract][Full Text] [Related]
31. Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult.
Huang C; Cui Y; Ji L; Zhang W; Li R; Ma L; Xing W; Zhou H; Chen B; Yu J; Zhang H
Pharm Biol; 2013 Apr; 51(4):463-73. PubMed ID: 23336403
[TBL] [Abstract][Full Text] [Related]
32. Late protective effect of pharmacological preconditioning with total flavones of rhododendra against myocardial ischemia-reperfusion injury.
Zhang JH; Chen ZW; Wu Z
Can J Physiol Pharmacol; 2008 Mar; 86(3):131-8. PubMed ID: 18418440
[TBL] [Abstract][Full Text] [Related]
33. Effects of aminoguanidine and cyclooxygenase inhibitors on nitric oxide and prostaglandin production, and nitric oxide synthase and cyclooxygenase expression induced by lipopolysaccharide in the estrogenized rat uterus.
Ribeiro M; Cella M; Farina M; Franchi A
Neuroimmunomodulation; 2004; 11(3):191-8. PubMed ID: 15067210
[TBL] [Abstract][Full Text] [Related]
34. Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts.
Di Napoli P; Taccardi AA; Grilli A; De Lutiis MA; Barsotti A; Felaco M; De Caterina R
Cardiovasc Res; 2005 Jun; 66(3):462-71. PubMed ID: 15914111
[TBL] [Abstract][Full Text] [Related]
35. Effect of atorvastatin on 5-fluorouracil-induced experimental oral mucositis.
Medeiros CA; Leitão RF; Macedo RN; Barboza DR; Gomes AS; Nogueira NA; Alencar NM; Ribeiro RA; Brito GA
Cancer Chemother Pharmacol; 2011 May; 67(5):1085-100. PubMed ID: 20661736
[TBL] [Abstract][Full Text] [Related]
36. Atorvastatin post-conditioning attenuates myocardial ischemia reperfusion injury via inhibiting endoplasmic reticulum stress-related apoptosis.
Xia JG; Xu FF; Qu Y; Song DG; Shen H; Liu XH
Shock; 2014 Oct; 42(4):365-71. PubMed ID: 25004060
[TBL] [Abstract][Full Text] [Related]
37. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2.
Dawn B; Xuan YT; Guo Y; Rezazadeh A; Stein AB; Hunt G; Wu WJ; Tan W; Bolli R
Cardiovasc Res; 2004 Oct; 64(1):61-71. PubMed ID: 15364614
[TBL] [Abstract][Full Text] [Related]
38. Effect of atorvastatin on expression of IL-10 and TNF-alpha mRNA in myocardial ischemia-reperfusion injury in rats.
Sun YM; Tian Y; Li X; Liu YY; Wang LF; Li J; Li ZQ; Pan W
Biochem Biophys Res Commun; 2009 May; 382(2):336-40. PubMed ID: 19275881
[TBL] [Abstract][Full Text] [Related]
39. Neuroinflammatory role of prostaglandins during experimental meningitis: evidence suggestive of an in vivo relationship between nitric oxide and prostaglandins.
Boje KM; Jaworowicz D; Raybon JJ
J Pharmacol Exp Ther; 2003 Jan; 304(1):319-25. PubMed ID: 12490607
[TBL] [Abstract][Full Text] [Related]
40. Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway.
Bell RM; Yellon DM
J Am Coll Cardiol; 2003 Feb; 41(3):508-15. PubMed ID: 12575984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
